We are live on ! Find out more
AAP

Aristotle Atlantic Partners Portfolio holdings

AUM $2.14B
1-Year Est. Return 37.01%
This Fund
S&P 500
This Quarter Est. Return
+10.82%
1 Year Est. Return
+37.01%
3 Year Est. Return
+123.74%
5 Year Est. Return
+154.13%
10 Year Est. Return
AUM
$1.72B
AUM Growth
+$211M
Cap. Flow
+$74.4M
Cap. Flow %
4.32%
Top 10 Hldgs %
43.42%
Holding
104
New
5
Increased
59
Reduced
10
Closed
3

Top Sells

Rank Stock Value
1
TFX icon
Teleflex
TFX
+$18.5M
2
QRVO icon
Qorvo
QRVO
+$12.5M
3
NVDA icon
NVIDIA
NVDA
+$11.5M
4
MRK icon
Merck
MRK
+$4.05M
5
BMY icon
Bristol-Myers Squibb
BMY
+$1.86M

Sector Composition

Rank Sector Weight
1 Technology 31.45%
2 Healthcare 17.04%
3 Consumer Discretionary 13.41%
4 Industrials 10.91%
5 Financials 9.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DXCM icon
26
DexCom
DXCM
$27.6B
$21.6M 1.25%
160,864
+776
+0.5% +$112K
GPN icon
27
Global Payments
GPN
$22.1B
$21.6M 1.25%
159,446
+3,314
+2% +$457K
ADPT icon
28
Adaptive Biotechnologies
ADPT
$3.56B
$20.9M 1.21%
745,795
+18,461
+3% +$566K
GH icon
29
Guardant Health
GH
$19.5B
$20.2M 1.17%
202,353
+7,423
+4% +$768K
TWLO icon
30
Twilio
TWLO
$29.1B
$20.2M 1.17%
76,769
+531
+0.7% +$159K
ROP icon
31
Roper Technologies
ROP
$36.3B
$17.6M 1.02%
35,856
+20
+0.1% +$9.52K
XOM icon
32
ExxonMobil
XOM
$651B
$15.5M 0.9%
253,482
SNOW icon
33
Snowflake
SNOW
$92.9B
$15.2M 0.88%
44,732
+1,180
+3% +$411K
SNPS icon
34
Synopsys
SNPS
$71.5B
$14.8M 0.86%
+40,090
New +$13.5M
AVGO icon
35
Broadcom
AVGO
$1.82T
$13.7M 0.79%
205,500
+19,980
+11% +$1.12M
AMP icon
36
Ameriprise Financial
AMP
$46.8B
$13.3M 0.77%
44,118
+5,205
+13% +$1.54M
MAR icon
37
Marriott International
MAR
$98.7B
$12M 0.69%
72,336
+14,403
+25% +$2.27M
AMT icon
38
American Tower
AMT
$77.7B
$11.7M 0.68%
40,000
ABT icon
39
Abbott
ABT
$180B
$11.6M 0.67%
82,246
+30,362
+59% +$3.89M
BAC icon
40
Bank of America
BAC
$435B
$11.2M 0.65%
251,129
+50,055
+25% +$2.28M
PH icon
41
Parker-Hannifin
PH
$125B
$10.4M 0.61%
32,770
IOVA icon
42
Iovance Biotherapeutics
IOVA
$2.23B
$10M 0.58%
+525,538
New +$11.6M
MCHP icon
43
Microchip Technology
MCHP
$42.8B
$9.95M 0.58%
114,278
+22,778
+25% +$1.84M
CRWD icon
44
CrowdStrike
CRWD
$187B
$9.93M 0.58%
193,972
+179,764
+1,265% +$10.9M
ICE icon
45
Intercontinental Exchange
ICE
$82.4B
$9.24M 0.54%
67,578
+13,458
+25% +$1.78M
PCH
46
DELISTED
PotlatchDeltic
PCH
$9.13M 0.53%
151,661
CMCSA icon
47
Comcast
CMCSA
$79.1B
$8.93M 0.52%
177,514
+35,377
+25% +$1.84M
CB icon
48
Chubb
CB
$140B
$8.58M 0.5%
44,383
+8,841
+25% +$1.66M
BMY icon
49
Bristol-Myers Squibb
BMY
$127B
$8.38M 0.49%
134,430
-31,655
-19% -$1.86M
MUSA icon
50
Murphy USA
MUSA
$11.3B
$8.35M 0.48%
41,913

Similar funds

Aristotle Atlantic Partners's Q4 2021 Portfolio in Review

As of Q4 2021, Aristotle Atlantic Partners held 104 positions worth $1.72B, up 14% from $1.51B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Aristotle Atlantic Partners deployed $74.4M of net new capital in Q4 2021, opening 5 new positions and adding to 59 existing holdings. Its largest new stake was Synopsys: 40,090 shares worth $14.8M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Teleflex, an estimated $18.5M trimmed.

  • Aristotle Atlantic Partners's largest Q4 2021 buy was Synopsys: 40,090 shares worth $14.8M.
  • Aristotle Atlantic Partners added most to CrowdStrike in Q4 2021, an estimated $10.9M increase.
  • Aristotle Atlantic Partners's biggest Q4 2021 reduction was Teleflex, cutting an estimated $18.5M.
  • Aristotle Atlantic Partners fully exited Qorvo in Q4 2021, selling an estimated $12.5M.
  • Aristotle Atlantic Partners's ten largest holdings make up 43% of its $1.72B portfolio in Q4 2021.
  • Aristotle Atlantic Partners opened 5 new positions and closed 3 in Q4 2021.
  • Aristotle Atlantic Partners's portfolio value rose 14% quarter-over-quarter to $1.72B.

Based on Aristotle Atlantic Partners's 13F filing for Q4 2021, filed 14 Feb 2022.